The Annals of Thoracic Surgery, Год журнала: 2024, Номер 118(3), С. 710 - 711
Опубликована: Авг. 23, 2024
Язык: Английский
The Thoracic and Cardiovascular Surgeon, Год журнала: 2025, Номер unknown
Опубликована: Март 27, 2025
Abstract For the 11th consecutive time, we systematically reviewed cardio-surgical literature for past year (2024), using PRISMA approach a results-oriented summary. In 2024, discussion on value of randomized and registry evidence increased, triggered by consistent findings in field coronary artery disease (CAD) discrepant results structural heart disease. The 2024 again confirmed excellent long-term outcomes CABG compared with PCI different scenarios, generating further validation advantage reported studies. This has been reflected new guidelines chronic CAD 2024. Two studies indicate novel perspectives CABG, showing that cardiac shockwave therapy improves myocardial function ischemic hearts guided computed tomography is safe feasible. aortic stenosis, an early transcatheter (TAVI) surgical (SAVR) treatment found more support; however, TAVI keep being challenged, this FDA data favor SAVR. failed valves, redo-SAVR showed superior valve-in-valve TAVI. mitral field, short-term noninferiority surgery secondary regurgitation (MR), significant survival benefit registries primary MR. Finally, was associated better medical acute type A intramural hematoma. article summarizes publications perceived as important us. It cannot be complete nor free individual interpretation but provides up-to-date information patient-specific decision-making.
Язык: Английский
Процитировано
0
Arquivos Brasileiros de Cardiologia, Год журнала: 2025, Номер 122(2)
Опубликована: Янв. 1, 2025
Язык: Английский
Процитировано
0
Arquivos Brasileiros de Cardiologia, Год журнала: 2025, Номер 122(2)
Опубликована: Янв. 1, 2025
Процитировано
0
The Annals of Thoracic Surgery, Год журнала: 2024, Номер 118(3), С. 710 - 711
Опубликована: Авг. 23, 2024
Язык: Английский
Процитировано
0